FDA Posts Three Form 483s for Foreign Manufacturers

In its continuing effort to step up post-pandemic enforcement activities, the FDA wrapped up 2023 by making public three Form 483s for as many Indian pharmaceutical manufacturers.
Source: Drug Industry Daily